close
Öffnungszeiten: Mo. - Do. 08:00 bis 17:00 Uhr | Fr. 08:00 bis 14:00
Westdeutsches Prostatazentrum Logo
close

PSMA-PET/CT: Lokalrezidiv oder metastasierter Tumor?

Literatur / Quellen
  1. The CHAPPP study: Changing care with PSMA-PET for Prostate cancer—A ret-rospective study of the role of PSMA imaging in altering treatment pathways, ASCO February 16, 2017
  2. Afshar-Oromieh A, Zechmann CM, et al. :Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20. doi: 10.1007/s00259-013-2525-5. Epub 2013 Sep 27.
  3. Afshar-Oromieh A, Haberkorn U, et al: Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19.